$ESAB

ESAB Corp

1
2
0

No SEC Form 4 filings for $ESAB in the last 30 days.

Med

ESAB’s (NYSE:ESAB) Q2 CY2026 Sales Beat Estimates

ESAB (NYSE:ESAB) reported Q2 CY2026 revenue of $807.6 million, up 12.9% year over year, exceeding Wall Street estimates by 2.6%. Non-GAAP EPS was $1.33, down from $1.36 a year earlier and 3% below consensus. Operating margin fell to 9.7% from the prior year. Analysts expect full-year EPS to rise from $5.31 to $6.08.

ESAB Corp (ESAB): Results of Operations and Financial Condition

ESAB Corp (ESAB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q22026earningspressrelease.htm EX-99.1 Document ESAB Corporation Announces Second Quarter 2026 Results • Record total sales increased 12.9%, with core organic sales up 2.5% • Core organic growth in both segments • Closed Eddyfi ahead of schedule • Updating 2026 outlook

ESAB Earnings: What To Look For From ESAB

ESAB (NYSE: ESAB) is set to report earnings Thursday before market hours. Last quarter, ESAB posted revenue of $745.6 million, up 9.9% year on year, but missed analysts on EPS. For the upcoming quarter, analysts expect about 10% revenue growth. The article cites an average price target of $135.40 versus a $94.76 share price.

ESAB sentiment & insider activity

Over the past 7 days, alphai's AI scored 3 news stories mentioning ESAB (ESAB Corp). Coverage has skewed bullish: 1 bullish, 2 neutral, and 0 bearish.

Recent ESAB coverage spans financial news, earnings and corporate actions.

What's driving ESAB

  • Revenue beat with EPS miss and operating margin decline suggests near-term earnings quality concerns despite top-line strength.

    financialcontent.com · Aug 6, 2026

  • Guidance raise plus acquisition close ahead of schedule should support near-term sentiment and earnings expectations, though margin guidance still reflects transitory cost pressures.

    SEC EDGAR 8-K · Aug 6, 2026

  • The piece frames consensus and recent estimate behavior ahead of ESAB’s earnings, but provides no new post-close datapoint beyond prior-quarter results.

    financialcontent.com · Aug 5, 2026

  • This is a compensation-plan disclosure; it may affect near-term sentiment only marginally, with limited direct fundamental impact.

    SEC EDGAR 8-K · Jun 12, 2026

  • Weaker-than-expected Q4 margins with price actions and volume sensitivity can create a mixed reaction.

    thehindubusinessline.com · May 29, 2026

alphai scores every news story that mentions ESAB with an AI model for sentiment and relevance, and aggregates insider trades from ESAB Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $ESAB

Score

ESAB’s (NYSE:ESAB) Q2 CY2026 Sales Beat Estimates

ESAB (NYSE:ESAB) reported Q2 CY2026 revenue of $807.6 million, up 12.9% year over year, exceeding Wall Street estimates by 2.6%. Non-GAAP EPS was $1.33, down from $1.36 a year earlier and 3% below consensus. Operating margin fell to 9.7% from the prior year. Analysts expect full-year EPS to rise from $5.31 to $6.08.

$ESABHigh

ESAB Corp (ESAB): Results of Operations and Financial Condition

ESAB Corp (ESAB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q22026earningspressrelease.htm EX-99.1 Document ESAB Corporation Announces Second Quarter 2026 Results • Record total sales increased 12.9%, with core organic sales up 2.5% • Core organic growth in both segments • Closed Eddyfi ahead of schedule • Updating 2026 outlook

ESAB Earnings: What To Look For From ESAB

ESAB (NYSE: ESAB) is set to report earnings Thursday before market hours. Last quarter, ESAB posted revenue of $745.6 million, up 9.9% year on year, but missed analysts on EPS. For the upcoming quarter, analysts expect about 10% revenue growth. The article cites an average price target of $135.40 versus a $94.76 share price.

$ESABLow

ESAB Corp (ESAB): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

ESAB Corp (ESAB) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 ea029454901ex10-1.htm FORM OF PERFORMANCE NON-QUALIFIED STOCK OPTION AGREEMENT Exhibit 10.1 ESAB Corporation 2022 Omnibus Incentive Plan Form of Performance Non-Qualified Stock Option Agreement ESAB Corporation, a Delaware corporation (the “Company”), hereby grants an o

Q4 Results 29th May Live: Asian Paints, IndiGo, NMDC, Glenmark Pharma, Ipca Lab, IREDA, Gujarat Gas, Natco Pharma, Inox Wind, Rubicon Research, BEML, NMDC Steel, JM Financial, Triveni Engg to announce

The article previews Q4 results from multiple Indian companies and highlights several earnings updates. Prime Focus reported standalone net profit of Rs 4.32 crore for March 2026 quarter vs Rs 16.11 crore loss a year earlier. Alkem Laboratories’ standalone net profit fell to Rs 217 crore from Rs 276.9 crore; it recommended a final dividend of Rs 10/share. It also cites Q4FY26 figures for ESAB India, Ecos Mobility, and Ivalue Infosolutions, plus early stock moves.

ESAB stockholders elect directors and approve proposals at annual meeting By Investing.com

ESAB Corporation stockholders have elected nine directors, ratified Ernst & Young LLP as their independent auditor, and approved executive compensation at their annual meeting. This information comes from a press release and an 8-K filing. The company also recently reported mixed Q1 2026 financial results, with increased revenue but lower-than-expected EPS, and announced a 20% quarterly dividend hike.

$ESABLow

ESAB Corp (NYSE: ESAB) CFO receives new stock option and RSU grants

ESAB Corp's EVP and CFO, R. Brent Jones, was granted 14,210 employee stock options and 33,978 restricted stock units (RSUs) on May 7, 2026. The stock options have an exercise price of $102.39 per share and expire on May 6, 2033, while both the options and RSUs will vest in three equal annual installments starting after the first anniversary of the grant date. These equity awards are designed to align his compensation with the company's long-term performance and encourage retention.

$ESABMed

Mitsubishi UFJ Trust & Banking Corp Sells 50,626 Shares of ESAB Corporation $ESAB

Mitsubishi UFJ Trust & Banking Corp reduced its stake in ESAB Corporation by 41.3%, selling 50,626 shares and retaining 72,005 shares valued at approximately $8.04 million. This move comes alongside other institutional investor changes and a significant insider sale by CEO Shyam Kambeyanda. Despite analyst price target reductions, ESAB maintains a "Moderate Buy" consensus rating with an average target price well above its current trading price.

$ESABLow

USU2959EAB9 Bond Analysis — Key Metrics

This article provides key metrics for the ESAB Corporation 5.625% 01-APR-2031 bond, identified by USU2959EAB9, traded on the Frankfurt Stock Exchange. It details the bond's issuer, issue date, maturity date, face value, minimum denomination, and a fixed coupon rate of 5.63%. The information is presented as an overview for investors.

Analysts Conflicted on These Industrial Goods Names: V2X (VVX), ESAB Corporation (ESAB) and Ebara (OtherEBCOF)

The article reports on analyst ratings for three industrial goods companies: V2X (VVX), ESAB Corporation (ESAB), and Ebara (EBCOF). Tobey Sommer from Truist Financial maintained a Hold rating on V2X with a consensus price target of $70.50. J.P. Morgan analyst Tami Zakaria issued a Buy rating for ESAB Corporation, setting a price target of $153.00, while Goldman Sachs' Shuhei Nakamura maintained a Buy rating on Ebara with a price target of Yen6600.00.

Related tickers